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Reasons for negative guidance included uncertainties in the clini-
cal evidence presented; and lack of a robust economic argument.
Completed industry submissions in oncology presented ICERs
ranging from 4,726 to 30,100. The corresponding ERG
group estimates of ICERs ranged from 4,726 to 86,770. The
ERG’s criticisms of the industry submissions included omission
of a systematic review, failure to use recommended approaches to
evidence synthesis and failure to adhere to the reference case.
CONCLUSION: The single technology appraisal process is in its
infancy with contributors gaining valuable experience with each
new appraisal. Acknowledging and acting upon the criticism
from ERGs will help improve the quality, and possibly the out-
comes of future STAs. Reviewing completed STAs and analysing
trends and themes may inform future strategic and tactical plan-
ning of submissions.
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EXAMINING INCENTIVES FOR SUBGROUPING IN
NICE SUBMISSIONS
Muston D
Heron Evidence Development Ltd, Letchworth, Hertfordshire, UK
OBJECTIVES: To assess existing incentives for indication sub-
grouping in NICE reimbursement submissions using a simple
probabilistic model. The model allows for uncertainty and makes
explicit assumptions regarding market size, price, subgrouping,
cost-effectiveness, market share and reimbursement acceptance.
METHODS: The Ofﬁce of Fair Trading in the UK has recently
recommended reform of the UK Pharmaceutical Price Regulation
Scheme from proﬁt limitation to one of value-based pricing. It
has been debated whether such a move would encourage the
targeting of cost-effective subgroups, or whether further incen-
tives would help the UK National Health Service receive a greater
share of net health beneﬁt. We have extended an existing proba-
bilistic model of manufacturer pricing decisions to encompass a
continuum of patient cost-effectiveness. Uncertainty can be incor-
porated at the patient and market level. A revenue probability
distribution function was derived as a function of price. With this
model, we explored the incentives that already exist for the
targeting of cost-effective subpopulations using a probabilistic
assessment of risks to product revenue streams. We calculated the
revenue probability density function under a range of subgroup-
ing scenarios assuming the drug is priced such that, over the
whole indicated population, the ICER is £30,000 per QALY.
RESULTS: We produced summary statistics from the probability
density functions indicative of the level of risk to the product
revenue available to the manufacturer, dependent on a number of
assumptions. In an example, targeting 20%, 80% and 100% of
an indicated population produced expected annual revenues of
£16.0 m, £51.7 m and £14.1 m respectively. Probabilities of gen-
erating revenues exceeding £15 m were 91%, 80% and 17%
respectively. CONCLUSION: The revenue probability distribu-
tion function provides a useful tool to guide pharmaceutical
pricing decisions, according to a company’s risk proﬁle. With
rational, probabilistic assessment of risk to product revenue
streams, it can be shown that incentives already exist for indica-
tion subgrouping.
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OBJECTIVES: To investigate doctors’ prescribing behavior in
Greece. METHODS: Data was derived from a closed question-
naire applied to a random stratiﬁed sample consisting of 1463
doctors. The response rate was 82.3%. Analysis of categorical
data concerned the calculation of descriptive measures, frequen-
cies and relative frequencies, and test of independence using
Chi-square test. RESULTS: Drugs’ effectiveness, appearance of
side effects and drug cost for the patient has been shown the most
important criteria for prescription. Younger and less experienced
doctors seem to take more into account drug cost, dosage and
side effects. Scientiﬁc journals, medical conferences and literature
review are referred as the main information sources about drug’s
effectiveness. As less signiﬁcant sources of inﬂuence are men-
tioned the sales’ representatives of pharmaceutical companies
and the internet. It is revealed that sales’ representatives of phar-
maceutical companies don’t affect physicians’ prescription deci-
sion, due to the fact that they believe that the information sales’
representatives of pharmaceutical companies provide, focuses
mainly in drugs’ advantages. Regarding the internet use it seems
that Greek doctors, mainly the older ones, are not familiar with
the use of new technologies and they prefer printed information
from journals and literature. Furthermore, it is mentioned that
any attempt of reforming drugs’ reimbursement policy doesn’t
affect the volume and the cost of prescribing. In general, physi-
cians have a positive opinion about generics, even though only
3.6% prescribes generics frequently. Male doctors tend to pre-
scribe generics more often. The majority of doctor’s believe that
the price of new drugs is too high compared to their improved
effectiveness. CONCLUSION: Knowledge of the proﬁle prescrip-
tion of doctors could be a useful tool for supply—side drug
policy interventions. Such studies combined with patients
reported outcomes could contribute to the qualitative and quan-
titative evaluation of drugs’ policy.
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OBJECTIVES: RTR is a regional telemedicine network allowing
consultancy between local and university hospitals located in
Toulouse. RTR offers tele-consultations and distance training for
practitioners located in isolated zones of access. This communi-
cation between different centres allows a better decision-making
regarding the necessity of transferring patients to university hos-
pitals. This study is a further step to the telemedicine tariffs study.
To evaluate the health insurance savings associated with RTR
network. METHODS: A pool of neurosurgery patients for
whom telemedicine consultation led to released or avoided trans-
fer was identiﬁed. The rate of modiﬁed transfer decisions due to
teleconsultations was derived from patients’ ﬁles. IN all, 240
patients’ ﬁles of neurosurgery were analysed but only 172 pro-
vided the information on initial needs of transfer. 58 out of those
172 ﬁles corresponded to avoided transfers. Hospitalisation asso-
ciated costs were identiﬁed from DRGs’ tariffs. Practitioners
clariﬁed the main diagnosis what allowed to identify the corre-
sponding DRG’s. Costs related to patients’ medical transfers
(such as the use of helicopters or ambulances) to university
hospitals were also computed. In order to assess the global RTR’s
impact, results observed from exploitable ﬁles have been
extrapolated to the whole population (240 patients). RESULTS:
For the 172 informed ﬁles, hospitalization cost savings:
EUR198,643; transportation cost savings: EUR172,533. In
2005, Telemedicine consultation led to a total savings of
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EUR371,177 for 172 patients, an average cost by transfer
avoided of EUR6,399. For the 240 patients consultations, the
total costs savings was estimated at more than EUR851,148.
CONCLUSION: These encouraging results suggest that RTR
/1related expenses can largely be compensated by direct and
indirect medical costs savings. This study has been realiseed with
other diagnosis: the results are convergent with the neurosurgical
approach.
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OBJECTIVES: The accrediting body for US Colleges of Phar-
macy [Accreditation Council for Pharmacy Education (ACPE)]
has recently updated their standards and guidelines (adopted in
January 2006, effective as of July 2007) which include an outline
of the topics that should be included in the curricula. These
include topics related to pharmacoeconomics. The objective of
this study was to determine the extent of pharmacoeconomic
education (PE) in US Colleges of Pharmacy (COP) in 2007.
METHODS: A survey was e-mailed to a professor at each of the
90 US Colleges of Pharmacy. The survey asked respondents to
indicate if pharmacoeconomic-related topics were covered in
their PharmD curricula. If so, the respondent was asked to list: 1)
the number of hours devoted to PE topics; 2) whether these were
in a required or elective course; 3) the number of students in the
course; 4) the learning objectives; 5) the resources (books/
articles) used; and 6) the topics covered. RESULTS: Six schools
did not currently provide PE, 17 did not provide complete data,
and 5 only provided PE in elective courses, leaving data on 62
schools for this analysis. For required PharmD courses (N = 62),
the mean number of hours devoted to these topics was 21 (range
1–48; median = 20). The mean number of students was 123
(range 45–300; median = 110). Tables with the most common
learning objectives, resources, and topics will be presented.
CONCLUSION: While the majority of US Colleges of Pharmacy
included pharmacoeconomic-related topics in their required
PharmD curriculum, most did not have a full course on the topic,
and some only devoted a minimum number of classroom hours
to this topic. A survey of all non-US Colleges of Pharmacy is
currently being conducted, and a survey of US Medical Schools is
planned.
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OBJECTIVES: Palliative care services (PCS), including pain man-
agement, end-of-life planning and counseling, remain uncommon
in many USA hospitals. This study assessed the prevalence of
potential candidates for PCS in a publicly-funded, acute-care
hospital. METHODS: A consult tool was developed to identify
potential need for PCS. For two months, two critical care nurses
surveyed all patients in surgical and medical intensive care, and
intermediate care units. The tool included 3 items tallied to create
a total score. These related to basic and concomitant disease
processes, and functional status (based on the Eastern Coopera-
tive Oncology Group or ECOG scale). Under basic disease
process, each life-threatening/terminal condition was 2 points.
Under concomitant disease process, each comorbid condition
was 1 point. The ECOG scale was scored from 0 to 3 (3 = com-
pletely disabled). Patients receiving a total score of >3 were
considered potential candidates for PCS. RESULTS: A total of
258 cases were reviewed; 140 (54%) were in intensive care units
(ICU), while 118 (46%) were in the intermediate unit (IMC). Of
the 258 cases, 105 (41%) achieved a total score >3, suggesting
PCS candidates. Of the 105, 59 (56%) were in ICUs. Median
total score was 3 (range 0–10), corresponding to need for con-
tinued observation. Median functional status score was 1 (range
0–3), indicating a patient was ambulatory, capable of self-care,
and awake more than 50% of waking hours. However, 42 (16%)
patients had a functional score of 3, indicating they were com-
pletely disabled, unable to provide any self-care, and conﬁned to
bed. CONCLUSION: PCS may be needed in 41% of critical care
admissions at a community hospital. The beneﬁts of PCS to
patients, payers, and providers have been demonstrated in mul-
tiple studies, but programs offering these services are infrequent.
Further research on the impact that PCS has on patient care is
needed to promote such programs.
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OBJECTIVES: To increase access to essential medicines by the
poor, Remediar Program in Argentina performs a strategy based
on the free provision of drugs at the public primary care centers.
As a secondary objetive, the Program proposed a reorientation
of the demand from hospitals to the primare care centers. The
goals of this study are twofold: 1) to analyze the impact gener-
ated by the increase of health care demand induced by Reme-
diar in the quality of primary health care services, according to
health team members perception, and 2) to identify the vari-
ables (geographical, professional based, and Program based)
that affect physiciansx satisfaction. METHODS: Argentine ter-
ritory was divided into six regions, and surveys were design and
collected from June to October 2005. Frequency and multivari-
ate analysis were developed, incorporating logistic regresions
(probit and linear models). RESULTS: Results show that 18%
of professionals considered that duration of consultations did
not change, while 31% believed that it changed signiﬁcantly.
Only 10% understood that consultation duration had grown
“too much”, difﬁculting their job. Regarding the daily number
of consultations, 69% considered that it increased since Reme-
diar started, causing, according to 56% of respondents, a drop
in the quality of the service. Health team satisfaction with the
Progran was tested against a group of variables; a gap in pro-
fessional satisfaction was identiﬁed between the Northeast
(high) and the Northwest (low) region, the poorest areas in
Argentina. Good perception increased with higher levels of the
Programxs pharmaceutical coverage. On the other side, low
levels of satisfaction were related to work overload before
Remediar was launched. CONCLUSION: Although an increase
of coverage was a main goal, results shows that the demand
induced by Remediar did not have a correlation with supply
planning, measured as infrastructure and professional ofﬁce
hours, affecting health care quality.
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